I & S presentation , provides shareholders with some
future direction .
However , there are concerns with the figures provided
Cost of sales in years (cos) 11 - 38% , 12 - 33% , 13 - 38%
in FY14 - Revenue 5.46m and ebitda of -4.13m
4.0m in wages , 2.1 m cos 1 m product development
costs then fixed costs ie rent.... ok
in Fy15 - Revenue 13.23 m , cos (assume 38%) 5.02 m
ebitda -.81 m WHAT !! ?????
in FY16 - Revenue 22.32 m , cos 8.48 m ebita 1.67 m
I must be missing something ,
eg revenue 22.32 m
less cos 8.48 m
less fixed costs 5.00 m ( wages , rent etc..)
ebitda 8.90 m
expected ebitda 1.67 m
that's 7 m difference , maybe an increased sales marketing expense is the reason , maybe not
Combining mining sales and truck sales
In FY 14 sales 156 (150 + 6) revenue 5.46 m
Average price received 35000 per sibs
In FY 15 sales 760 , revenue 13.23 m
Ave 17047 per unit
In FY 16 sales 1590 , revenue 22.32 m
Ave 14037 per unit
Well , it does explain the thin margins
- Forums
- ASX - By Stock
- Ann: ABV - Investor and Strategy Presentation
I & S presentation , provides shareholders with some future...
Featured News
Add ABV (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.8¢ |
Change
-0.001(1.12%) |
Mkt cap ! $28.70M |
Open | High | Low | Value | Volume |
9.0¢ | 9.0¢ | 8.8¢ | $21.89K | 244.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8791 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 131787 | 0.012 |
1 | 100000 | 0.010 |
1 | 700561 | 0.009 |
2 | 10000000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 371498 | 2 |
0.015 | 528000 | 2 |
0.016 | 119374 | 2 |
0.017 | 687500 | 3 |
0.019 | 575000 | 1 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
ABV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online